Perampanel Inhibits α-Synuclein Transmission in Parkinson's Disease Models.
Jun UedaNorihito UemuraMasanori SawamuraTomoyuki TaguchiMasashi IkunoSeiji KajiYosuke TarunoShuichi MatsuzawaHodaka YamakadoRyosuke TakahashiPublished in: Movement disorders : official journal of the Movement Disorder Society (2021)
Modulation of neuronal activity could be a promising therapeutic target for Parkinson's disease, and perampanel could be a novel disease-modifying drug for Parkinson's disease. © 2021 International Parkinson and Movement Disorder Society.